PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Researcher

Linfang Wang

Laboratory Medicine Center, Department of Clinical Laboratory, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, People's Republic of China.

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

JUL 2, 2026 · JOURNAL ARTICLE

Distinct effects of GES variants on ceftazidime-avibactam and imipenem-relebactam resistance in carbapenem-resistant Pseudomonas aeruginosa: a ten-year retrospective study.

Emerging Microbes & Infections

Laboratory and genomic analysis identifies subtype-specific GES variant resistance patterns to novel β-lactam/inhibitor combinations in a retrospective collection, but lacks clinical outcome data.

PreliminaryLinfang Wang Fengyao Yi Tailong Lei

Reported

Sample size916 CRPA isolates

blaGES-positive isolates50

GES-1 prevalence68%

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support